Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. H. Lundbeck A/S
  6. News
  7. Press Releases
    LUN   DK0010287234

H. LUNDBECK A/S

(LUN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société H. LUNDBECK A/S
07/22H LUNDBECK A/S : What do you mean brain health?
PU
06/15#1VOICESUMMIT : Partnering with the advocacy community to further brain health a..
PU
06/11H LUNDBECK A/S : Lundbeck CEO, Deborah Dunsire, warns that we could be on the br..
PU
05/31H LUNDBECK A/S : Interpretation Of The Term "export" In The Indian Patent Contex..
AQ
05/26H LUNDBECK A/S : Transactions with shares and linked securities in H. Lundbeck A..
AQ
05/24H LUNDBECK A/S : The Hunt for a New Weapon Against Schizophrenia
PU
05/11H LUNDBECK A/S : Lundbeck delivers a solid EBIT of DKK 882 million and Vyepti is..
AQ
05/03H LUNDBECK A/S : Lundbeck - New study finds that vortioxetine helps patients wit..
AQ
05/03H LUNDBECK A/S : New study finds that vortioxetine helps patients with MDD and c..
AQ
04/22H LUNDBECK A/S : Vortioxetine significantly improves overall functioning in a gl..
AQ
04/13H LUNDBECK A/S : Lundbeck and Otsuka announce decision to continue phase III cli..
PU
04/13H LUNDBECK A/S : Lundbeck and Otsuka announce decision to continue phase III cli..
AQ
03/23H LUNDBECK A/S : Lundbeck held its Annual General Meeting on 23 March 2021 as a ..
AQ
03/17H LUNDBECK A/S : Lundbeck appoints Dr. Tarek Samad as Head of Research
AQ
03/12H LUNDBECK A/S : Supplement to notice of Annual General Meeting
PU
03/12H LUNDBECK A/S : Lundbeck – New member proposed for election to Board of D..
PU
03/12H LUNDBECK A/S : Lundbeck - New member proposed for election to Board of Directo..
AQ
03/04H LUNDBECK A/S : Transactions with shares and linked securities in H. Lundbeck A..
AQ
03/01H LUNDBECK A/S : Lundbeck A/S - Notice of Annual General Meeting
AQ
02/08H LUNDBECK A/S : Transactions with shares and linked securities in H. Lundbeck A..
PU
02/04H LUNDBECK A/S : Transactions with shares and linked securities in H. Lundbeck A..
AQ
02/04H LUNDBECK A/S : Sustainability Report
PU
02/04H LUNDBECK A/S : Lundbeck sets new 15-year climate target, towards achieving net..
PU
02/04H LUNDBECK A/S : Annual Report 2020 for H. Lundbeck A/S
AQ
02/04H LUNDBECK A/S : In an unprecedented year, Lundbeck delivers sales growth of 4% ..
AQ
01/12H LUNDBECK A/S : Rigshospitalet and Lundbeck announce partnership to find new wa..
AQ
01/06H. LUNDBECK A/S : - Adjusted Supplementary Information to the Annual Report 2019
AQ
01/05H LUNDBECK A/S : Adjusted Supplementary Information to the Annual Report 2019
AQ
2020H LUNDBECK A/S : The Danish Business Authority (“Erhvervsstyrelsen”)..
PU
2020H LUNDBECK A/S : Lundbeck announces European Medicines Agency acceptance of mark..
AQ
2020H LUNDBECK A/S : Lundbeck is ranked as one of the world's leading companies for ..
PU
2020H LUNDBECK A/S : Lundbeck is ranked as one of the world's leading companies for ..
AQ
2020SENZAGEN : receives SEK 0.4 m order for GARD®skin and GARD®air tests from pharma..
AQ
2020H LUNDBECK A/S : The Danish Business Authority requires Lundbeck to conduct a ne..
AQ
2020H LUNDBECK A/S : The Danish Business Authority ("Erhvervsstyrelsen") requires Lu..
AQ
2020H LUNDBECK A/S : Solid performance across strategic brands with 19% growth in th..
AQ
2020H LUNDBECK A/S : Lundbeck successfully places its first EUR 500 million Eurobond..
AQ
2020H LUNDBECK A/S : Lundbeck successfully places its first EUR 500 million Eurobond..
AQ
2020H LUNDBECK A/S : Lundbeck presents positive data from the COMPLETE study with vo..
AQ
2020H LUNDBECK A/S : Lundbeck presents positive data from the COMPLETE study with vo..
AQ
2020H. LUNDBECK A/S : - Positive headline results from the Vyepti RELIEF study
AQ
2020H LUNDBECK A/S : Strong momentum across all strategic brands with 25% growth in ..
AQ
2020H LUNDBECK A/S : Lundbeck discontinues phase II proof of concept study of Lu AF1..
AQ
2020H LUNDBECK A/S : Lundbeck plans to refocus and reinvigorate Research & Developme..
AQ
2020H LUNDBECK A/S : Transactions with shares and linked securities in H. Lundbeck A..
AQ
2020H LUNDBECK A/S : Strong momentum across all strategic brands with 35% growth in ..
AQ
2020H. LUNDBECK A/S : - High school students compete online in developing future med..
AQ
2020H LUNDBECK A/S : High school students compete online in developing future medici..
AQ
2020H LUNDBECK A/S : Lundbeck announces phase IIa study results of Lu AG06466 in adu..
AQ
2020H LUNDBECK A/S : Lundbeck reports headline results from phase IIa AMBLED study o..
AQ
2020H LUNDBECK A/S : Lundbeck announces phase IIa study results of Lu AG06466 in adu..
AQ
2020H LUNDBECK A/S : Lundbeck reports headline results from phase IIa AMBLED study o..
AQ
2020H LUNDBECK A/S : Lundbeck held its Annual General Meeting on 24 March 2020 at th..
AQ
2020H LUNDBECK A/S : Lundbeck receives grant from The Michael J. Fox Foundation for ..
AQ
2020H LUNDBECK A/S : Transactions with shares and linked securities in H. Lundbeck A..
AQ
2020H LUNDBECK A/S : Lundbeck A/S - Notice of Annual General Meeting
AQ
2020H LUNDBECK A/S : Notice of Annual General Meeting
AQ
2020H LUNDBECK A/S : FDA approves Lundbeck's Vyepti (eptinezumab-jjmr) – the f..
PU
2020H LUNDBECK A/S : FDA approves Lundbeck's Vyepti (eptinezumab-jjmr) - the first a..
AQ
2020H LUNDBECK A/S : Lundbeck increases its share capital by 11,497 shares as a resu..
AQ
2020H LUNDBECK A/S : Lundbeck increases its share capital by 11,497 shares (0.0058 %..
AQ
2020H LUNDBECK : Transactions with shares and linked securities in H. Lundbeck A/S m..
AQ
2020H LUNDBECK : Annual Report 2019 for H. Lundbeck A/S
AQ
2020H LUNDBECK : Strong momentum with 28% growth across all strategic brands in 2019..
AQ
2020H LUNDBECK : Lundbeck ranked among world's climate elite
AQ
2018H LUNDBECK : Survey Findings Highlight the Burden of Neurogenic Orthostatic Hypo..
BU
2018H LUNDBECK : Lundbeck starts clinical development of potential new treatment of ..
PU
2018H LUNDBECK : Lundbeck and Otsuka's Rxulti® (brexpiprazole) receives positive opi..
PU
2018H LUNDBECK : Lundbeck divests preclinical research programs
PU
2018H LUNDBECK : Lundbeck expands its clinical pipeline
PU
2018H LUNDBECK : Lundbeck enters research partnership on novel treatment of schizoph..
PU
2017H LUNDBECK : Lundbeck's Brintellix approved in China
PU
2017H LUNDBECK : Study Evaluates Refractory Epilepsy Screening Tool for LGS (REST-LG..
BU
2017H LUNDBECK : Transactions with shares and linked securities in H. Lundbeck A/S m..
PU
2017H LUNDBECK : Transactions with shares and linked securities in H. Lundbeck A/S m..
PU
1  2  3  4  5Next
Upcoming event on H. LUNDBECK A/S
08/18/21